Ekso Bionics Holdings Profit Margin

Ekso Bionics Holdings (EKSO) currently reports a profit margin of -135.66% as of March 2026. That compares with -61.51% in the prior-year period — down 120.5% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Ekso Bionics Holdings's profit margin history and peer comparisons.

Ekso Bionics Holdings's profit margin decreased from -61.51% to -135.66% — a 120.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ekso Bionics Holdings's profit margin of -135.66% is lower than the Healthcare sector average of 13.89%. That is roughly 1076.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ekso Bionics Holdings's current -135.66% should be judged against Healthcare norms (sector average: 13.89%) and against EKSO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -135.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Ekso Bionics Holdings, and consider following EKSO for alerts when major investors trade the stock.